97 percent of the participants developed antibodies
Hope in the fight against HIV! Vaccine study delivers amazing results
Researchers at the US company Moderna have developed a vaccine that is intended to prevent infections with the HI virus.
www.imago-images.de, imago images/photothek, Ute Grabowsky/photothek.net via www.imago-images.de
in the fight against the corona virus window.dataLayer.push(event: ‘link_click’,link_type: ‘intern’,link_url: ‘https://www.rtl.de/cms/corona-impfung-wie-wirkt-ein-mrna-impfstoff-forscher -erlaeren-aktion-des-koerpers-4805157.html’))()”> mRNA-based vaccines made the crucial turn. US researchers at The Scripps Research Institute hope that this will now also be possible in HIV prevention. In cooperation with the US company Moderna, they have developed a vaccine that treats infections with the window.dataLayer.push(event: ‘link_click’,link_type: ‘intern’,link_url: ‘https://www.rtl.de/themen/thema/hiv-t9052.html’))()”> HI-Virus should prevent. The first phase of the study, in which the vaccine is tested on humans, is now complete – and is delivering encouraging results.
HIV antibodies in 97 percent of study participants
97 percent of the study participants developed antibodies after receiving the vaccine, is the astonishing interim result of the study, which was published in the journal Science at the beginning of December. A total of 48 subjects took part in the small phase 1 study. Twelve of them received a placebo. Of the 36 subjects who received the vaccine, 35 developed antibodies. None of the candidates experienced serious side effects. Some participants reported pain at the injection site or mild to moderate headaches. The next test phases of the study should now show whether these results are also reflected in larger groups of people.
Reading Tip: window.dataLayer.push(event: ‘link_click’,link_type: ‘intern’,link_url: ‘https://www.rtl.de/cms/dank-stammzelltherapie-erste-frau-von-hiv-heiled-4919944 .html’))()”> Medical sensation! First woman cured of HIV
Share your experiences with us!
The result of this survey is not representative.
Recommendations from our partners
How is the HIV vaccine supposed to work?
The mRNA vaccine aims to stimulate the production of antibodies in the human body. It is important here that broadly neutralizing antibodies are produced. Because the HI virus mutates frequently, the vaccine must therefore be able to be effective against numerous HIV variants in order to be able to prevent infection. Multiple vaccinations may be needed to establish this broad immunity. Each vaccination could then contain a different HIV component to train the immune system.
“It’s a whole new way of thinking about how to make a vaccine,” study author William Schief said in an interview with Sciencealert. One is optimistic that this approach could not only be helpful for HIV. (and)